001     119273
005     20240228145431.0
024 7 _ |a 10.1002/mrm.26100
|2 doi
024 7 _ |a pmid:26845067
|2 pmid
024 7 _ |a 0740-3194
|2 ISSN
024 7 _ |a 1522-2594
|2 ISSN
024 7 _ |a altmetric:5096533
|2 altmetric
037 _ _ |a DKFZ-2017-00059
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Zaiss, Moritz
|0 P:(DE-He78)db923d831c5fe9b5e8fab7794dd45c44
|b 0
|e First author
|u dkfz
245 _ _ |a Downfield-NOE-suppressed amide-CEST-MRI at 7 Tesla provides a unique contrast in human glioblastoma.
260 _ _ |a New York, NY [u.a.]
|c 2017
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1525770664_9511
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The chemical exchange saturation transfer (CEST) effect observed in brain tissue in vivo at the frequency offset 3.5 ppm downfield of water was assigned to amide protons of the protein backbone. Obeying a base-catalyzed exchange process such an amide-CEST effect would correlate with intracellular pH and protein concentration, correlations that are highly interesting for cancer diagnosis. However, recent experiments suggested that, besides the known aliphatic relayed-nuclear Overhauser effect (rNOE) upfield of water, an additional downfield rNOE is apparent in vivo resonating as well around +3.5 ppm. In this study, we present further evidence for the underlying downfield-rNOE signal, and we propose a first method that suppresses the downfield-rNOE contribution to the amide-CEST contrast. Thus, an isolated amide-CEST effect depending mainly on amide proton concentration and pH is generated.The isolation of the exchange mediated amide proton effect was investigated in protein model-solutions and tissue lysates and successfully applied to in vivo CEST images of 11 glioblastoma patients.Comparison with gadolinium contrast enhancing longitudinal relaxation time-weighted images revealed that the downfield-rNOE-suppressed amide-CEST contrast forms a unique contrast that delineates tumor regions and show remarkable overlap with the gadolinium contrast enhancement.Thus, suppression of the downfield rNOE contribution might be the important step to yield the amide proton CEST contrast originally aimed at. Magn Reson Med 77:196-208, 2017. © 2016 Wiley Periodicals, Inc.
536 _ _ |a 315 - Imaging and radiooncology (POF3-315)
|0 G:(DE-HGF)POF3-315
|c POF3-315
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Windschuh, Johannes
|0 P:(DE-He78)98b696ed60c17f4ddd0da9fdc20a2492
|b 1
|u dkfz
700 1 _ |a Goerke, Steffen
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Paech, Daniel
|0 P:(DE-He78)c6e31fb8f19e185e254174554a0cccfc
|b 3
|u dkfz
700 1 _ |a Meissner, Jan-Eric
|0 P:(DE-He78)65fe7a46247e2ac4b15f194631c56cd1
|b 4
|u dkfz
700 1 _ |a Burth, Sina
|b 5
700 1 _ |a Kickingereder, Philipp
|0 P:(DE-He78)3da06896bf2a50a84d40c33c3b7a9b3e
|b 6
|u dkfz
700 1 _ |a Wick, Wolfgang
|0 P:(DE-He78)92e9783ca7025f36ce14e12cd348d2ee
|b 7
|u dkfz
700 1 _ |a Bendszus, Martin
|b 8
700 1 _ |a Schlemmer, Heinz-Peter
|0 P:(DE-He78)3d04c8fee58c9ab71f62ff80d06b6fec
|b 9
|u dkfz
700 1 _ |a Ladd, Mark
|0 P:(DE-He78)022611a2317e4de40fd912e0a72293a8
|b 10
|u dkfz
700 1 _ |a Bachert, Peter
|0 P:(DE-He78)29b2f01310f7022916255ddba2750f9b
|b 11
|u dkfz
700 1 _ |a Radbruch, Alexander
|0 P:(DE-He78)77588f5b9413339755a66e739d316c7d
|b 12
|e Last author
|u dkfz
773 _ _ |a 10.1002/mrm.26100
|g Vol. 77, no. 1, p. 196 - 208
|0 PERI:(DE-600)1493786-4
|n 1
|p 196 - 208
|t Magnetic resonance in medicine
|v 77
|y 2017
|x 0740-3194
909 C O |p VDB
|o oai:inrepo02.dkfz.de:119273
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)db923d831c5fe9b5e8fab7794dd45c44
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)98b696ed60c17f4ddd0da9fdc20a2492
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)c6e31fb8f19e185e254174554a0cccfc
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)65fe7a46247e2ac4b15f194631c56cd1
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)3da06896bf2a50a84d40c33c3b7a9b3e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)92e9783ca7025f36ce14e12cd348d2ee
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)3d04c8fee58c9ab71f62ff80d06b6fec
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)022611a2317e4de40fd912e0a72293a8
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)29b2f01310f7022916255ddba2750f9b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)77588f5b9413339755a66e739d316c7d
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-315
|2 G:(DE-HGF)POF3-300
|v Imaging and radiooncology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2017
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MAGN RESON MED : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)E020-20160331
|k E020
|l Medizinische Physik in der Radiologie
|x 0
920 1 _ |0 I:(DE-He78)E010-20160331
|k E010
|l Radiologie
|x 1
920 1 _ |0 I:(DE-He78)E012-20160331
|k E012
|l Neuroonkologische Bildgebung
|x 2
920 1 _ |0 I:(DE-He78)G370-20160331
|k G370
|l KKE Neuroonkologie
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)E020-20160331
980 _ _ |a I:(DE-He78)E010-20160331
980 _ _ |a I:(DE-He78)E012-20160331
980 _ _ |a I:(DE-He78)G370-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21